Kinnate Biopharma (KNTE) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free KNTE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Kinnate Biopharma Short Interest DataCurrent Short Volume465,600 sharesPrevious Short Volume825,000 sharesChange Vs. Previous Month-43.56%Dollar Volume Sold Short$1.19 millionShort Interest Ratio / Days to Cover1.2Last Record DateMarch 15, 2024Outstanding Shares47,220,000 sharesFloat Size23,170,000 sharesShort Percent of Float2.01%Today's Trading Volume2,812,200 sharesAverage Trading Volume418,678 sharesToday's Volume Vs. Average672% Short Selling Kinnate Biopharma ? Sign up to receive the latest short interest report for Kinnate Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKNTE Short Interest Over TimeKNTE Days to Cover Over TimeKNTE Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Kinnate Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024465,600 shares $1.19 million -43.6%2.0%1.2 $2.56 2/29/2024825,000 shares $2.04 million -23.6%3.6%2.2 $2.47 2/15/20241,080,000 shares $2.45 million -1.8%4.7%2.7 $2.27 1/31/20241,100,000 shares $2.61 million +5.8%5.6%0.8 $2.37 1/15/20241,040,000 shares $2.57 million -23.5%5.3%0.8 $2.47 12/31/20231,360,000 shares $3.22 million +16.2%6.9%1.1 $2.37 Get the Latest News and Ratings for KNTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kinnate Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/20231,170,000 shares $2.68 million -15.8%5.9%0.9 $2.29 11/30/20231,390,000 shares $3.16 million +31.1%7.1%1.2 $2.27 11/15/20231,060,000 shares $2.65 million No Change5.4%0.9 $2.50 10/31/20231,060,000 shares $1.18 million -3.6%5.4%6.9 $1.11 10/15/20231,100,000 shares $1.52 million +13.9%5.6%6.4 $1.38 9/30/2023966,200 shares $1.35 million +3.3%4.9%5.1 $1.40 9/15/2023935,700 shares $1.59 million -20.7%4.7%4.5 $1.70 8/31/20231,180,000 shares $2.63 million -18.6%6.1%4 $2.23 8/15/20231,450,000 shares $3.81 million -4.0%7.4%4.3 $2.63 7/31/20231,510,000 shares $4.48 million No Change7.9%3.5 $2.97 7/15/20231,510,000 shares $4.64 million -9.6%7.9%2.7 $3.07 6/30/20231,670,000 shares $5.06 million -23.0%8.8%3 $3.03 6/15/20232,170,000 shares $7.25 million +29.9%11.4%4 $3.34 5/31/20231,670,000 shares $7.18 million No Change8.8%3.8 $4.30 5/15/20231,670,000 shares $7.13 million +10.6%8.8%4.3 $4.27 4/30/20231,510,000 shares $3.82 million -16.6%6.9%4.7 $2.53 4/15/20231,810,000 shares $9.88 million No Change7.6%12.2 $5.46 3/31/20231,810,000 shares $11.31 million -10.4%7.6%15.5 $6.25 3/15/20232,020,000 shares $9.43 million +20.2%8.9%17.4 $4.67 2/28/20231,680,000 shares $8.87 million +7.0%7.8%14.2 $5.28 2/15/20231,570,000 shares $10.69 million +27.6%7.3%12.9 $6.81 1/31/20231,230,000 shares $9.26 million -2.4%5.6%9.7 $7.53 1/15/20231,260,000 shares $8.06 million -3.8%5.8%10.4 $6.40 12/30/20221,310,000 shares $7.99 million -53.7%6.0%7.6 $6.10 12/15/20222,830,000 shares $17.72 million -11.3%13.0%15.5 $6.26 11/30/20223,190,000 shares $25.26 million -3.3%14.6%16.9 $7.92 11/15/20223,300,000 shares $33.36 million -6.5%15.1%18.2 $10.11 10/31/20223,530,000 shares $29.76 million +0.6%16.7%18.9 $8.43 10/15/20223,510,000 shares $30.50 million -11.4%19.6%19 $8.69 9/30/20223,960,000 shares $47.32 million +13.5%22.1%29.9 $11.95 9/15/20223,490,000 shares $42.54 million +9.8%20.1%24.8 $12.19 8/31/20223,180,000 shares $46.05 million +0.3%18.4%21.1 $14.48 8/15/20223,170,000 shares $47.55 million +0.3%18.2%19.3 $15.00 7/31/20223,160,000 shares $33.81 million -0.9%18.0%19.2 $10.701970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP KNTE Short Interest - Frequently Asked Questions What is Kinnate Biopharma's current short interest? Short interest is the volume of Kinnate Biopharma shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 465,600 shares of KNTE short. 2.01% of Kinnate Biopharma's shares are currently sold short. Learn More on Kinnate Biopharma's current short interest. What is a good short interest ratio for Kinnate Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KNTE shares currently have a short interest ratio of 1.0. Learn More on Kinnate Biopharma's short interest ratio. Which institutional investors are shorting Kinnate Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kinnate Biopharma: Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Kinnate Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.01% of Kinnate Biopharma's floating shares are currently sold short. Is Kinnate Biopharma's short interest increasing or decreasing? Kinnate Biopharma saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 465,600 shares, a drop of 43.6% from the previous total of 825,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kinnate Biopharma's float size? Kinnate Biopharma currently has issued a total of 47,220,000 shares. Some of Kinnate Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kinnate Biopharma currently has a public float of 23,170,000 shares. How does Kinnate Biopharma's short interest compare to its competitors? 2.01% of Kinnate Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Kinnate Biopharma: LianBio (0.36%), Abeona Therapeutics Inc (7.95%), Vistagen Therapeutics, Inc. (5.31%), Immunic, Inc. (3.20%), Cartesian Therapeutics, Inc. (45.28%), MSP Recovery, Inc. (4.43%), Karyopharm Therapeutics Inc. (20.23%), Coya Therapeutics, Inc. (1.47%), So-Young International Inc. (0.06%), Inotiv, Inc. (5.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Kinnate Biopharma stock? Short selling KNTE is an investing strategy that aims to generate trading profit from Kinnate Biopharma as its price is falling. KNTE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kinnate Biopharma? A short squeeze for Kinnate Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KNTE, which in turn drives the price of the stock up even further. How often is Kinnate Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KNTE, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LIAN Short Squeeze ABEO Short Squeeze VTGN Short Squeeze IMUX Short Squeeze RNAC Short Squeeze LIFW Short Squeeze KPTI Short Squeeze COYA Short Squeeze SY Short Squeeze NOTV Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KNTE) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders